IMGN logo

ImmunoGen (IMGN) Cash From Financing

Annual CFF

$27.55 M
-$328.19 M-92.25%

December 31, 2022

Summary

Performance

1-Year Change

-92.25%

3-Year Change

+859.07%

5-Year Change

-72.61%

15-Year Change

-72.61%

IMGN Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$355.74 M
IMGN annual cash flow from financing activities is currently -92.25% below its historical high of $355.74 million

3-Year Low

$27.55 M
IMGN annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

Annual CFI

-$1.36 M
IMGN annual cash flow from investing activities is -$1.36 million

Annual CFO

-$229.80 M
IMGN annual cash flow from operations is -$229.80 million

Annual FCF

-$231.17 M
IMGN annual free cash flow is -$231.17 million

Annual CAPEX

$1.36 M
IMGN annual capital expenditures is $1.36 million

Quarterly CFF

$32.13 M
-$405.43 M-92.66%

September 30, 2023

Summary

Performance

3-Month Change

-92.66%

1-Year Change

+7056.35%

3-Year Change

+24808.53%

5-Year Change

+33370.83%

IMGN Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$437.56 M
IMGN quarterly cash flow from financing activities is currently -92.66% below its historical high of $437.56 million

3-Year Low

$39.00 K
IMGN quarterly cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

Quarterly CFI

-$1.35 M
IMGN quarterly cash flow from investing activities is -$1.35 million

Quarterly CFO

$2.77 M
IMGN quarterly cash flow from operations is $2.77 million

Quarterly FCF

$1.42 M
IMGN quarterly free cash flow is $1.42 million

Quarterly CAPEX

$1.35 M
IMGN quarterly capital expenditures is $1.35 million

TTM CFF

$495.80 M
+$31.68 M+6.83%

September 30, 2023

Summary

Performance

3-Month Change

+6.83%

1-Year Change

+76.62%

3-Year Change

+392.85%

5-Year Change

+17157.29%

IMGN TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$495.80 M
IMGN TTM cash flow from financing activities is currently at an all-time high

3-Year Low

$26.97 M
IMGN TTM cash flow from financing activities is currently +1738.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

TTM CFI

-$1.89 M
IMGN TTM cash flow from investing activities is -$1.89 million

TTM CFO

-$197.89 M
IMGN TTM cash flow from operations is -$197.89 million

TTM FCF

-$199.78 M
IMGN TTM free cash flow is -$199.78 million

TTM CAPEX

$1.89 M
IMGN TTM capital expenditures is $1.89 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IMGN Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-92.3%+7056.4%+76.6%
3 y3 years+859.1%+10000.0%+392.9%
5 y5 years-72.6%+10000.0%+10000.0%

IMGN Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.3%at low-92.7%-99.9%at high-94.6%
5 y5-year-92.3%-89.6%-92.7%-99.9%at high-99.4%
alltimeall time-92.3%-140.2%-92.7%-114.1%at high-102.2%

ImmunoGen Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2023
-
$32.13 M(-92.7%)
$495.80 M(+6.8%)
Jun 2023
-
$437.56 M(>+9900.0%)
$464.12 M(+1620.7%)
Mar 2023
-
$39.00 K(-99.9%)
$26.97 M(-2.1%)
Dec 2022
$27.55 M(-92.3%)
$26.07 M(+5707.1%)
$27.55 M(-90.2%)
Sep 2022
-
$449.00 K(+9.2%)
$280.71 M(-12.7%)
Jun 2022
-
$411.00 K(-33.7%)
$321.65 M(+0.0%)
Mar 2022
-
$620.00 K(-99.8%)
$321.59 M(-9.6%)
Dec 2021
$355.74 M(+81.7%)
$279.23 M(+574.6%)
$355.74 M(+104.8%)
Sep 2021
-
$41.39 M(>+9900.0%)
$173.72 M(+31.2%)
Jun 2021
-
$344.00 K(-99.0%)
$132.46 M(-0.1%)
Mar 2021
-
$34.78 M(-64.2%)
$132.54 M(-32.3%)
Dec 2020
$195.74 M(+6713.2%)
$97.21 M(>+9900.0%)
$195.74 M(+94.6%)
Sep 2020
-
$129.00 K(-69.5%)
$100.60 M(+0.1%)
Jun 2020
-
$423.00 K(-99.6%)
$100.54 M(-0.2%)
Mar 2020
-
$97.98 M(+4651.9%)
$100.79 M(+3408.1%)
Dec 2019
$2.87 M(-98.3%)
$2.06 M(+2724.7%)
$2.87 M(+32.5%)
Sep 2019
-
$73.00 K(-89.1%)
$2.17 M(-1.0%)
Jun 2019
-
$670.00 K(+885.3%)
$2.19 M(-98.7%)
Mar 2019
-
$68.00 K(-95.0%)
$164.62 M(-1.3%)
Dec 2018
$166.81 M(+65.8%)
$1.36 M(+1314.6%)
$166.81 M(-37.6%)
Sep 2018
-
$96.00 K(-99.9%)
$267.39 M(+0.5%)
Jun 2018
-
$163.10 M(+7120.0%)
$265.94 M(+158.5%)
Mar 2018
-
$2.26 M(-97.8%)
$102.87 M(+2.2%)
Dec 2017
$100.61 M(>+9900.0%)
$101.93 M(-7639.5%)
$100.61 M(-7722.3%)
Sep 2017
-
-$1.35 M(-4325.0%)
-$1.32 M(-4225.0%)
Jun 2017
-
$32.00 K(-100.0%)
$32.00 K(-100.0%)
Dec 2016
$0.00(-100.0%)
-
-
Jun 2016
$101.77 M(-48.7%)
$96.79 M(>+9900.0%)
$101.77 M(-49.6%)
Mar 2016
-
$188.00 K(-42.9%)
$202.11 M(+0.0%)
Dec 2015
-
$329.00 K(-92.6%)
$202.04 M(-0.4%)
Sep 2015
-
$4.46 M(-97.7%)
$202.88 M(+2.2%)
Jun 2015
$198.56 M(+2073.4%)
$197.13 M(>+9900.0%)
$198.56 M(+9773.9%)
Mar 2015
-
$116.00 K(-90.1%)
$2.01 M(-40.8%)
Dec 2014
-
$1.17 M(+713.9%)
$3.40 M(-35.4%)
Sep 2014
-
$144.00 K(-75.1%)
$5.25 M(-42.5%)
Jun 2014
$9.14 M(-90.7%)
$579.00 K(-61.5%)
$9.14 M(-11.9%)
Mar 2014
-
$1.50 M(-50.4%)
$10.37 M(+1.3%)
Dec 2013
-
$3.03 M(-24.7%)
$10.23 M(+39.2%)
Sep 2013
-
$4.03 M(+122.6%)
$7.35 M(-92.5%)
Jun 2013
$98.02 M(+1302.6%)
$1.81 M(+32.3%)
$98.02 M(-1.2%)
Mar 2013
-
$1.37 M(+823.6%)
$99.19 M(-0.6%)
Dec 2012
-
$148.00 K(-99.8%)
$99.74 M(-1.2%)
Sep 2012
-
$94.69 M(+3076.6%)
$100.97 M(+1344.8%)
Jun 2012
$6.99 M(-92.3%)
$2.98 M(+55.5%)
$6.99 M(-92.5%)
Mar 2012
-
$1.92 M(+39.5%)
$93.79 M(+1.6%)
Dec 2011
-
$1.37 M(+91.9%)
$92.32 M(+1.1%)
Sep 2011
-
$716.00 K(-99.2%)
$91.30 M(+0.7%)
Jun 2011
$90.70 M(+12.0%)
$89.79 M(>+9900.0%)
$90.70 M(+14.5%)
Mar 2011
-
$441.00 K(+25.3%)
$79.19 M(-0.2%)
Dec 2010
-
$352.00 K(+193.3%)
$79.32 M(-1.6%)
Sep 2010
-
$120.00 K(-99.8%)
$80.59 M(-0.5%)
Jun 2010
$80.98 M(+105.8%)
$78.28 M(>+9900.0%)
$80.98 M(+96.6%)
Mar 2010
-
$575.00 K(-64.6%)
$41.18 M(-0.1%)
Dec 2009
-
$1.62 M(+219.1%)
$41.22 M(+3.5%)
Sep 2009
-
$509.00 K(-98.7%)
$39.83 M(+1.2%)
Jun 2009
$39.36 M(+51.3%)
$38.47 M(+6135.7%)
$39.36 M(+52.0%)
Mar 2009
-
$617.00 K(+174.2%)
$25.90 M(+2.3%)
Dec 2008
-
$225.00 K(+423.3%)
$25.30 M(-2.2%)
Sep 2008
-
$43.00 K(-99.8%)
$25.88 M(-0.5%)
Jun 2008
$26.01 M(+1109.7%)
$25.01 M(>+9900.0%)
$26.01 M(+1621.3%)
Mar 2008
-
$23.00 K(-97.1%)
$1.51 M(-47.3%)
Dec 2007
-
$804.00 K(+370.2%)
$2.87 M(+25.0%)
Sep 2007
-
$171.00 K(-66.7%)
$2.29 M(+6.7%)
Jun 2007
$2.15 M
$513.00 K(-62.8%)
$2.15 M(+26.2%)
Mar 2007
-
$1.38 M(+497.4%)
$1.70 M(+49.3%)
DateAnnualQuarterlyTTM
Dec 2006
-
$231.00 K(+788.5%)
$1.14 M(+22.0%)
Sep 2006
-
$26.00 K(-60.6%)
$935.00 K(-18.7%)
Jun 2006
$1.15 M(+117.4%)
$66.00 K(-91.9%)
$1.15 M(+1.5%)
Mar 2006
-
$818.00 K(+3172.0%)
$1.13 M(+60.7%)
Dec 2005
-
$25.00 K(-89.6%)
$705.00 K(-8.0%)
Sep 2005
-
$241.00 K(+391.8%)
$766.00 K(+44.8%)
Jun 2005
$529.00 K(-11.7%)
$49.00 K(-87.4%)
$529.00 K(-38.3%)
Mar 2005
-
$390.00 K(+353.5%)
$858.00 K(+45.3%)
Dec 2004
-
$86.00 K(+2050.0%)
$590.30 K(-1.8%)
Sep 2004
-
$4000.00(-98.9%)
$601.00 K(+0.3%)
Jun 2004
$599.00 K(-105.4%)
$378.00 K(+209.1%)
$599.00 K(-3427.8%)
Mar 2004
-
$122.30 K(+26.5%)
-$18.00 K(-99.6%)
Dec 2003
-
$96.70 K(+4735.0%)
-$4.67 M(-45.2%)
Sep 2003
-
$2000.00(-100.8%)
-$8.52 M(-23.0%)
Jun 2003
-$11.07 M(-282.3%)
-$239.00 K(-94.7%)
-$11.07 M(+5.9%)
Mar 2003
-
-$4.53 M(+20.6%)
-$10.45 M(+79.6%)
Dec 2002
-
-$3.75 M(+47.4%)
-$5.82 M(+236.2%)
Sep 2002
-
-$2.55 M(-776.1%)
-$1.73 M(-128.5%)
Jun 2002
$6.07 M(-95.7%)
$376.60 K(+261.4%)
$6.07 M(+5.5%)
Mar 2002
-
$104.20 K(-68.8%)
$5.75 M(+2.3%)
Dec 2001
-
$334.50 K(-93.6%)
$5.62 M(-95.7%)
Sep 2001
-
$5.26 M(+8674.1%)
$130.63 M(-8.1%)
Jun 2001
$142.20 M(+1257.1%)
$59.90 K(-336.8%)
$142.20 M(-0.5%)
Mar 2001
-
-$25.30 K(-100.0%)
$142.99 M(-3.0%)
Dec 2000
-
$125.34 M(+645.0%)
$147.44 M(+514.2%)
Sep 2000
-
$16.83 M(+1892.4%)
$24.00 M(+129.1%)
Jun 2000
$10.48 M(+101.5%)
$844.50 K(-80.9%)
$10.48 M(-2.4%)
Mar 2000
-
$4.43 M(+132.6%)
$10.73 M(+49.0%)
Dec 1999
-
$1.90 M(-42.3%)
$7.20 M(+16.2%)
Sep 1999
-
$3.30 M(+200.0%)
$6.20 M(+19.2%)
Jun 1999
$5.20 M(-8.8%)
$1.10 M(+22.2%)
$5.20 M(+4.0%)
Mar 1999
-
$900.00 K(0.0%)
$5.00 M(-7.4%)
Dec 1998
-
$900.00 K(-60.9%)
$5.40 M(-14.3%)
Sep 1998
-
$2.30 M(+155.6%)
$6.30 M(+10.5%)
Jun 1998
$5.70 M(-17.4%)
$900.00 K(-30.8%)
$5.70 M(-1.7%)
Mar 1998
-
$1.30 M(-27.8%)
$5.80 M(-22.7%)
Dec 1997
-
$1.80 M(+5.9%)
$7.50 M(-12.8%)
Sep 1997
-
$1.70 M(+70.0%)
$8.60 M(+24.6%)
Jun 1997
$6.90 M(-17.9%)
$1.00 M(-66.7%)
$6.90 M(-11.5%)
Mar 1997
-
$3.00 M(+3.4%)
$7.80 M(-3.7%)
Dec 1996
-
$2.90 M(>+9900.0%)
$8.10 M(+62.0%)
Sep 1996
-
$0.00(-100.0%)
$5.00 M(-40.5%)
Jun 1996
$8.40 M(-1033.3%)
$1.90 M(-42.4%)
$8.40 M(+29.2%)
Mar 1996
-
$3.30 M(-1750.0%)
$6.50 M(+103.1%)
Dec 1995
-
-$200.00 K(-105.9%)
$3.20 M(-5.9%)
Sep 1995
-
$3.40 M(-1233.3%)
$3.40 M(-78.2%)
Jun 1995
-$900.00 K(-105.7%)
-
-
Sep 1994
-
-$300.00 K(-130.0%)
$15.60 M(-1.9%)
Jun 1994
$15.90 M(+1666.7%)
$1.00 M(-93.3%)
$15.90 M(+0.6%)
Mar 1994
-
$15.00 M(<-9900.0%)
$15.80 M(+1875.0%)
Dec 1993
-
-$100.00 K(<-9900.0%)
$800.00 K(-11.1%)
Sep 1993
-
$0.00(-100.0%)
$900.00 K(0.0%)
Jun 1993
$900.00 K(-97.2%)
$900.00 K(>+9900.0%)
$900.00 K(>+9900.0%)
Mar 1993
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1992
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1992
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 1992
$32.30 M(-16.1%)
-
-
Sep 1991
-
$0.00(-100.0%)
$38.50 M(0.0%)
Jun 1991
$38.50 M(+187.3%)
$3.10 M(-91.2%)
$38.50 M(+8.8%)
Mar 1991
-
$35.40 M(>+9900.0%)
$35.40 M(>+9900.0%)
Dec 1990
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1990
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1990
$13.40 M(+45.7%)
-
-
Sep 1989
-
$0.00
$0.00
Jun 1989
$9.20 M
-
-

FAQ

  • What is ImmunoGen annual cash flow from financing activities?
  • What is the all time high annual CFF for ImmunoGen?
  • What is ImmunoGen annual CFF year-on-year change?
  • What is ImmunoGen quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for ImmunoGen?
  • What is ImmunoGen quarterly CFF year-on-year change?
  • What is ImmunoGen TTM cash flow from financing activities?
  • What is the all time high TTM CFF for ImmunoGen?
  • What is ImmunoGen TTM CFF year-on-year change?

What is ImmunoGen annual cash flow from financing activities?

The current annual CFF of IMGN is $27.55 M

What is the all time high annual CFF for ImmunoGen?

ImmunoGen all-time high annual cash flow from financing activities is $355.74 M

What is ImmunoGen annual CFF year-on-year change?

Over the past year, IMGN annual cash flow from financing activities has changed by -$328.19 M (-92.25%)

What is ImmunoGen quarterly cash flow from financing activities?

The current quarterly CFF of IMGN is $32.13 M

What is the all time high quarterly CFF for ImmunoGen?

ImmunoGen all-time high quarterly cash flow from financing activities is $437.56 M

What is ImmunoGen quarterly CFF year-on-year change?

Over the past year, IMGN quarterly cash flow from financing activities has changed by +$31.68 M (+7056.35%)

What is ImmunoGen TTM cash flow from financing activities?

The current TTM CFF of IMGN is $495.80 M

What is the all time high TTM CFF for ImmunoGen?

ImmunoGen all-time high TTM cash flow from financing activities is $495.80 M

What is ImmunoGen TTM CFF year-on-year change?

Over the past year, IMGN TTM cash flow from financing activities has changed by +$215.09 M (+76.62%)